| Natural killer cells: development, maturation, and clinical utilization AM Abel, C Yang, MS Thakar, S Malarkannan Frontiers in immunology 9, 1869, 2018 | 1127 | 2018 |
| The molecular and functional characterization of a dominant minor H antigen, H60 S Malarkannan, PP Shih, PA Eden, T Horng, AR Zuberi, G Christianson, ... The Journal of Immunology 161 (7), 3501-3509, 1998 | 291 | 1998 |
| Heterogeneity of human bone marrow and blood natural killer cells defined by single-cell transcriptome C Yang, JR Siebert, R Burns, ZJ Gerbec, B Bonacci, A Rymaszewski, ... Nature communications 10 (1), 3931, 2019 | 228 | 2019 |
| IL-22 from conventional NK cells is epithelial regenerative and inflammation protective during influenza infection P Kumar, MS Thakar, W Ouyang, S Malarkannan Mucosal immunology 6 (1), 69-82, 2013 | 201 | 2013 |
| Presentation of out-of-frame peptide/MHC class I complexes by a novel translation initiation mechanism S Malarkannan, T Horng, PP Shih, S Schwab, N Shastri Immunity 10 (6), 681-690, 1999 | 144 | 1999 |
| Mitochondrial metabolic reprogramming by CD36 signaling drives macrophage inflammatory responses Y Chen, M Yang, W Huang, W Chen, Y Zhao, ML Schulte, P Volberding, ... Circulation research 125 (12), 1087-1102, 2019 | 143 | 2019 |
| Unanticipated antigens: translation initiation at CUG with leucine SR Schwab, JA Shugart, T Horng, S Malarkannan, N Shastri PLoS biology 2 (11), e366, 2004 | 141 | 2004 |
| Immune-checkpoint protein VISTA regulates antitumor immunity by controlling myeloid cell–mediated inflammation and immunosuppression W Xu, J Dong, Y Zheng, J Zhou, Y Yuan, HM Ta, HE Miller, M Olson, ... Cancer immunology research 7 (9), 1497-1510, 2019 | 128 | 2019 |
| The p110δ of PI3K plays a critical role in NK cell terminal maturation and cytokine/chemokine generation H Guo, A Samarakoon, B Vanhaesebroeck, S Malarkannan The Journal of experimental medicine 205 (10), 2419-2435, 2008 | 121 | 2008 |
| The structure, expression, and multifaceted role of immune-checkpoint protein VISTA as a critical regulator of anti-tumor immunity, autoimmunity, and inflammation W Xu, TM Hiếu, S Malarkannan, L Wang Cellular & molecular immunology 15 (5), 438-446, 2018 | 119 | 2018 |
| Signaling by Fyn-ADAP via the Carma1–Bcl-10–MAP3K7 signalosome exclusively regulates inflammatory cytokine production in NK cells K Rajasekaran, P Kumar, KM Schuldt, EJ Peterson, B Vanhaesebroeck, ... Nature immunology 14 (11), 1127-1136, 2013 | 111 | 2013 |
| Quantitative analysis of the immune response to mouse non-MHC transplantation antigens in vivo: the H60 histocompatibility antigen dominates over all others EY Choi, Y Yoshimura, GJ Christianson, TJ Sproule, S Malarkannan, ... The Journal of Immunology 166 (7), 4370-4379, 2001 | 105 | 2001 |
| Differences that matter: major cytotoxic T cell–stimulating minor histocompatibility antigens S Malarkannan, T Horng, P Eden, F Gonzalez, P Shih, N Brouwenstijn, ... Immunity 13 (3), 333-344, 2000 | 105 | 2000 |
| IQGAP1: insights into the function of a molecular puppeteer AM Abel, KM Schuldt, K Rajasekaran, D Hwang, MJ Riese, S Rao, ... Molecular immunology 65 (2), 336-349, 2015 | 104 | 2015 |
| The functional impairment of natural killer cells during influenza virus infection H Guo, P Kumar, TM Moran, A Garcia‐Sastre, Y Zhou, S Malarkannan Immunology and cell biology 87 (8), 579-589, 2009 | 98 | 2009 |
| Clinical relevance of natural killer cells following hematopoietic stem cell transplantation JM Palmer, K Rajasekaran, MS Thakar, S Malarkannan Journal of Cancer 4 (1), 25, 2013 | 94 | 2013 |
| A rare cryptic translation product is presented by Kb major histocompatibility complex class I molecule to alloreactive T cells. S Malarkannan, M Afkarian, N Shastri The Journal of experimental medicine 182 (6), 1739-1750, 1995 | 92 | 1995 |
| NKG2D receptor–mediated NK cell function is regulated by inhibitory Ly49 receptors J Regunathan, Y Chen, D Wang, S Malarkannan Blood 105 (1), 233-240, 2005 | 88 | 2005 |
| Real-time T-cell profiling identifies H60 as a major minor histocompatibility antigen in murine graft-versus-host disease EY Choi, GJ Christianson, Y Yoshimura, N Jung, TJ Sproule, ... Blood, The Journal of the American Society of Hematology 100 (13), 4259-4264, 2002 | 85 | 2002 |
| Tissue-resident NK cells: development, maturation, and clinical relevance E Hashemi, S Malarkannan Cancers 12 (6), 1553, 2020 | 83 | 2020 |
